Whitehawk Therapeutics, Inc.
WHWK
$1.90
$0.031.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.78M | 25.98M | 25.07M | 23.82M | 23.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.78M | 25.98M | 25.07M | 23.82M | 23.84M |
| Cost of Revenue | 49.36M | 54.05M | 52.61M | 54.40M | 54.50M |
| Gross Profit | -21.58M | -28.07M | -27.54M | -30.58M | -30.66M |
| SG&A Expenses | 38.94M | 36.75M | 36.04M | 40.08M | 43.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 88.30M | 90.80M | 88.66M | 94.48M | 98.46M |
| Operating Income | -60.53M | -64.82M | -63.59M | -70.66M | -74.62M |
| Income Before Tax | 27.61M | -63.69M | -61.69M | -65.44M | -68.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 27.61 | -63.69 | -61.69 | -65.44 | -68.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.61M | -63.69M | -61.69M | -65.44M | -68.83M |
| EBIT | -60.53M | -64.82M | -63.59M | -70.66M | -74.62M |
| EBITDA | -60.33M | -64.63M | -63.40M | -70.47M | -74.44M |
| EPS Basic | 0.16 | -2.36 | -2.29 | -2.43 | -2.55 |
| Normalized Basic EPS | -1.22 | -1.41 | -1.37 | -1.52 | -1.60 |
| EPS Diluted | 0.15 | -2.36 | -2.29 | -2.43 | -2.56 |
| Normalized Diluted EPS | -1.21 | -1.41 | -1.37 | -1.52 | -1.60 |
| Average Basic Shares Outstanding | 120.78M | 108.12M | 108.00M | 107.90M | 107.77M |
| Average Diluted Shares Outstanding | 121.07M | 108.12M | 108.00M | 107.90M | 107.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |